SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-19-000460
Filing Date
2019-11-27
Accepted
2019-11-27 10:05:16
Documents
7
Period of Report
2019-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnbt112219form8k.htm 8-K 32099
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 195561
3 GRAPHIC image_002.gif GRAPHIC 17933
4 GRAPHIC image_003.gif GRAPHIC 18868
5 GRAPHIC image_004.gif GRAPHIC 3657
6 GRAPHIC image_001.jpg GRAPHIC 59043
7 GRAPHIC image_001.gif GRAPHIC 2363
  Complete submission text file 0001607062-19-000460.txt   369565
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 191253667
SIC: 2834 Pharmaceutical Preparations